Even though GSK3β has not been demonstrated to produce epilepsy in itself, there is evidence showing that GSK3β inhibition does result in anticonvulsant activity, even after brain excitability has been altered from normal, healthy conditions into a “pro-epileptic” state (Aourz et al., 2019). Here, GSK3B is linked to epilepsy.